Condition: Hepato Cellular Carcinoma (HCC) · Intrahepatic Cholangiocarcinoma · Sponsor: University Hospital, Angers
Randomized multicentre trial comparing two care organisations (ambulatory vs conventional inpatient) for patients undergoing transarterial chemoembolization (TACE) or radioembolization (TARE) for primary liver cancer (Hepato Cellular Carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA)). Patients are followed for 7 months to assess patient satisfaction, safety and clinical outcomes. A qualitative implementation study and a medico-economic evaluation (cost analysis and 5-years budget impact analysis) are embedded to assess acceptability, adoption, feasability, and sustainability and to inform scaling.
This description comes directly from the study's public registry record.
Christophe AUBE, Pr · +33(0)24-135-4281 · ChAube@chu-angers.fr
Sandra MERZEAU · +33(0)24-135-5970 · SaMerzeau@chu-angers.fr
Always discuss trial participation with your own doctor first.
| University hospital of Amiens | Amiens, France | Recruiting |
| University hospital of Angers | Angers, France | Recruiting |
| University hospital of Besançon | Besançon, France | Recruiting |
| Hospital of Avicennes (AP-HP) | Bobigny, France | Recruiting |
| University hospital of Brest | Brest, France | Recruiting |
| Hospital of Beaujon (AP-HP) | Clichy, France | Recruiting |
| Hospital of Vendée | La Roche-sur-Yon, France | Recruiting |
| University hospital of Grenoble-Alpes | La Tronche, France | Recruiting |
| University hospital of Marseille (AP-HM) | Marseille, France | Recruiting |
| Saint-Joseph Hospital | Marseille, France | Recruiting |
| University hospital of Montpellier | Montpellier, France | Not Yet Recruiting |
| University hospital of Nantes | Nantes, France | Not Yet Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06990659